Clinical Trials Logo

Filter by:
NCT ID: NCT03993561 Completed - Clinical trials for Head and Neck Cancer

Treatment Summary and Survivorship Care Plans (TSSP)

SHARE
Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to establish the highest level of evidence to evaluate treatment summary and survivorship care plans (TSSPs) by piloting the TSSPs on patients with HNC. Hypothesis: HNC patients who receive the intervention of the TSSP will have an increased rate of implementation of recommendations for their needs, greater adherence with follow-up schedules, improved quality of life and improved satisfaction with post-treatment care. Aim 1 (Validation of TSSP): To validate a treatment summary and survivorship care plan (TSSP) intervention specifically tailored to the needs of HNC patients based on the best available evidence. Approach: In the first phase of the project the investigators will pilot the London Heath Sciences Centre TSSP with head and neck cancer survivors and then have the TSSP extensively reviewed and modified by our multidisciplinary head and neck oncology treatment team. Aim 2 (Evaluation of TSSP): To evaluate the implementation of a TSSP in survivors of head and neck cancer compared to usual treatment in a randomized fashion to determine whether TSSPs result in improved implementation of recommendations for HNC survivors and improved quality of life and satisfaction. Approach: In the second phase of the project the investigators will conduct a randomized controlled trial to compare patient reported outcomes in HNC patients who have received the TSSP to patients who have not received the TSSP.

NCT ID: NCT03993496 Recruiting - Clinical trials for Abdominal Aortic Aneurysm

Intraoperative Assessment of Pulsatile Aneurysm Wall Motion During Endovascular Aneurysm Repair

Start date: August 9, 2019
Phase:
Study type: Observational

Endovascular abdominal aortic aneurysm repair (EVAR) aims to reduce the risk of aneurysm (AAA) rupture by reducing the blood pressure transmitted to the wall of the aneurysm. Aneurysms that remain pressurized despite EVAR may continue to grow, therefore requiring additional surgical interventions. The purpose of this study is to infer the reduction of pressure transmitted to the aneurysm wall by using intraoperative ultrasound ('M-Mode') to assess the pulsatility of the aneurysm wall. The hypothesis is that intraoperative reduction in aneurysm wall pulsatility after EVAR will correlate with improved aneurysm sac size reduction.

NCT ID: NCT03993483 Completed - Muscle Strength Clinical Trials

Upper Versus Lower Limb Responses to Higher Versus Lower Load Resistance Training in Young Men

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Recent research suggests that performing resistance exercise training with relatively light loads is equally as effective at increasing muscle mass and muscle strength as performing resistance exercise training with relatively heavy loads. Whether or not performing resistance exercise with relatively heavy loads or light loads is equally as effective between the upper- and lower-body within the same individual has never been investigated. Given the substantial individual variance in resistance exercise training-induced changes in muscle mass and strength, this study is designed to quantify the relative influence that extrinsic training variables (e.g., load), as opposed to intrinsic muscle-based predisposition, has on resistance training-induced changes in muscle mass and muscle strength.

NCT ID: NCT03993366 Completed - Clinical trials for Type 1 Diabetes Mellitus

Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The aim of this pilot study is to generate preliminary data of (i) Fiasp-plus-Pramlintide closed-loop system with a simple meal announcement, compared to (ii) Fiasp-alone closed-loop system with full carbohydrate counting, in preparation for an outpatient study over two weeks

NCT ID: NCT03992118 Completed - Clinical trials for Autism Spectrum Disorder

Project LEaH: Learning to Eat at Home

Start date: August 7, 2018
Phase: N/A
Study type: Interventional

The investigators are trying to determine if delivery a feeding intervention program using videoconferencing technology is feasible.

NCT ID: NCT03992092 Recruiting - Clinical trials for Intubation Complication

Video Stylet vs. Flexible Bronchoscopy for C-Spine

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Comparison of cervical spine movement during intubation with the C-MAC Video Stylet to Flexible Bronchoscopy

NCT ID: NCT03991858 Completed - Rehabilitation Clinical Trials

Implementation of Telerehabilitation as Modality of Patient Follow-up on the Waiting List of a Clinic

Start date: March 13, 2019
Phase: N/A
Study type: Interventional

This study responds to the need to validate the feasibility and effectiveness of a telerehabilitation home monitoring program for users receiving a preliminary assessment while waiting for rehabilitation services at the outpatient physiotherapy clinic. The specific objectives are as followed: 1) Evaluate the implementation of telerehabilitation monitoring (TELE-FOLLOW-UP); 2) Evaluate the effectiveness of TELE-FOLLOW-UP compared to the usual phone call; 3) Evaluate user satisfaction for these two modes of service delivery; 4) Identify facilitators and barriers to the implementation of TELE-FOLLOW-UP. In order to meet the objectives of the study, mixed methods will be used. A randomized clinical trial will be used to achieve objectives 1, 2 and 3. The investigators plan to recruit 142 patients. Two groups will be formed: 1) TELE-FOLLOW-UP group: users who will receive follow-up by telerehabilitation; 2) PHONE-FOLLOW-UP group: those who will receive follow-up by a phone call.

NCT ID: NCT03991832 Recruiting - Solid Tumor Clinical Trials

Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors

SOLID
Start date: December 31, 2019
Phase: Phase 2
Study type: Interventional

This is a phase 2 study of the combination of drugs olaparib and durvalumab for the treatment of isocitrate dehydrogenase or (IDH) mutated solid tumors. The purpose of this study is to assess the efficacy of the drug combination via overall response rate and overall disease control rate. It is believed that giving olaparib and durvalumab together would be more useful when given to patients with IDH-mutated solid tumors than giving each drug alone.

NCT ID: NCT03991819 Recruiting - Clinical trials for Non-small Cell Carcinoma

Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer

Start date: September 20, 2019
Phase: Phase 1
Study type: Interventional

This is a Phase I/Ib study whose purpose is to find out if combining an experimental drug called binimetinib with pembrolizumab is beneficial in people who have advanced non-small cell lung cancer. This study may also see if the combination is safe and may also find the best dose of binimetinib that should be added to pembrolizumab.

NCT ID: NCT03991806 Active, not recruiting - Frailty Clinical Trials

Association of Centre of Excellence Self- Administered Questionnaire Score and Frailty Levels

Start date: May 31, 2020
Phase:
Study type: Observational

This study evaluates the frailty and the health adverse events in the population of the Canadian Longitudinal Study on Aging. It will be used the Centre of Excellence Self-Administered questionnaire (CESAM) which assesses frailty of older adults by providing a score and a of frailty in 4 levels.